Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business Group on Health said.
An article from
Dive Brief
Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business Group on Health said.
Published May 7, 2026
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023, in Los Angeles, Calif. Companies that don't provide coverage of GLP-1s for weight management are unlikely to add it, a new survey found.
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their…
As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for both…
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the…
Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.
Amazon's new GLP-1 push comes days after Walmart unveiled its own platform — as big players race to capture demand for the drugs.
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.
